ArticleFrontiers in microbiology2026
Multi-omics analysis reveals the modulatory effects of
Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The overuse of antimicrobial growth promoters (AGPs) in poultry farming has raised global concerns about antimicrobial resistance and food safety, prompting the search for effective natural alternatives. Moringa is rich in bioactive compounds with antimicrobial and immunomodulatory properties; however, its effects on the cecal microbiota and metabolome of broiler chickens when administered via drinking water remain unclear. Methods: This study employed 16S rDNA sequencing and non-targeted metabolomics to evaluate the effects of Results: The findings demonstrated MOE did not significantly affect α-diversity but altered β-diversity, resulting in a clear separation from the control and BZ groups. Linear discriminant analysis effect size (LEfSe) analysis identified Lachnospiraceae and Methanobacteriaceae as key differential biomarkers in the MOE group, whereas Deferribacterales was selectively enriched in the BZ group. At the phylum level, MOE enriched the Euryarchaeota, while BZ increased the abundance of potentially pathogenic phyla, including the Desulfobacterota and Proteobacteria. At the genus level, MOE promoted the growth of beneficial genera such as Conclusion: Overall, MOE is associated with alterations in cecal microbiota and host metabolism by enriching butyrate-producing bacteria and methanogenic archaea, accompanied by extensive metabolic reprogramming involving immune-related and antioxidant pathways.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.